Bumper Offer - Urjas oil Just @ Rs. 1
Imi Cila is a prescription drug, available for use as Injection. The alternative uses of Imi Cila have also been explained below.
The right dosage of Imi Cila depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Imi Cila as well, which are listed below. These side effects of Imi Cila are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Imi Cila's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Imi Cila related warnings talks about Imi Cila's effects on the liver, heart and kidney.
Imi Cila can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Imi Cila in conditions like Kidney Disease, Kidney Disease. Other contraindications of Imi Cila have been discussed in the sections ahead.
Drug interactions for Imi Cila have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Imi Cila is safe while driving, and is is addictive in nature.
Imi Cila is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Imi Cila is used -
Severe
Moderate
Mild
Is the use of Imi Cila safe for pregnant women?
Imi Cila may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Imi Cila again without your doctor's advice.
Is the use of Imi Cila safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Imi Cila. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Imi Cila on the Kidneys?
There may be some adverse effects on kidney after taking Imi Cila. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Imi Cila on the Liver?
You may experience side effects on your liver after taking Imi Cila. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Imi Cila on the Heart?
Side effects of Imi Cila rarely affect the heart.
Imi Cila should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imi Cila unless your doctor advises you to do so -
Is this Imi Cila habit forming or addictive?
No, there is no any evidence that Imi Cila is addictive.
Interaction between Food and Imi Cila
Imi Cila may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Imi Cila
Consumption of alcohol and Imi Cila together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678
